Table II.
Whole sporozoite vaccination approach | Vaccination-induced responses | ||
---|---|---|---|
Radiation-attenuated sporozoites (RAS) | CD8 T cells | CD4 T cells | Antibodies |
Mouse | Required for protection [29–33]. | Generally not required for protection, dependent on mouse strain [29]. | Anti-sporozoite antibodies did not correlate with protection [30]. |
Non-human primate | IFNγ+, TNFα+ CD8 T cells detected in liver following ex vivo sporozoite stimulation [33]. | IFNγ+, TNFα+, or IL-2+ CD4 T cells detected in liver following ex vivo sporozoite stimulation [33]. | N.D.* |
Human | Peripheral blood IFNγ+, TNFα+, IL-2+ CD8 T cells detected following ex vivo sporozoite stimulation [16]. | Peripheral blood IFNγ+, TNFα+, IL-2+ CD4 T cells detected following ex vivo sporozoite stimulation [16,33]. | Anti-CSP antibodies induced [16,33]. |
Genetically-attenuated parasites (GAP) | |||
Mouse | Required for protection [10, 36–39]. | Not required for protection [30,36,38]. | N.D.* |
Human | Peripheral blood IFNγ+ CD8 T cells detected following ex vivo sporozoite stimulation [18]. | Peripheral blood IFNγ+, TNFα+, IL-2+ CD4 T cells detected following ex vivo sporozoite stimulation [18]. | Antibodies capable of inhibiting in vitro hepatocyte invasion detected [18]. |
Infection-treatment vaccination Mouse | Requirement for protection differs by rodent/ parasite immunization model. Not required for protection in C57Bl/6-P. yoelii 17XNL [23]. Partially reduces liver parasite burden in BALB/c-P. yoelii YM265 model [9]. | Not required for protection – can delete population just prior to challenge [23]. Partially reduces liver parasite burden in BALB/c-P. yoelii YM265 model [9]. | Anti-blood-stage parasite antibodies correlated with protection in C57Bl/6-P. yoelii 17XNL model [23]. |
Human | Detectable peripheral blood IFNγ+, IL-2+ CD8 T cell response following ex vivo blood-stage parasite stimulation [21]. | Peripheral blood IFNγ+, IL-2+ CD4 T cell response following ex vivo blood-stage parasite stimulation [21]. | Anti-CSP antibodies induced [20,21]. |
Indicates not discussed in review.